Combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer
Combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer
Is there a role for androgen deprivation therapy combined with radiotherapy in intermediate risk prostate cancer?
Basal subtype predicts clinical benefit from neoadjuvant chemo in urothelial cancer
New approach to prostate cancer screening
Challenging results from mTOR inhibitors in metastatic clear cell renal cancer
Efficacy, tolerability and quality of life in metastatic renal cell carcinoma: Welcome and introduction
mRCC: Real-world experience: achieving efficacy beyond clinical trials
mRCC: Are we doing all we can to manage adverse events?
mRCC: Understanding the patient's perspective
mRCC: Panel discussion
mRCC: Closing remarks
ecancermedicalscience Special Issue: Fertility sparing